Alnylam PharmaceuticalsALNY 
$274.950.18%24h
0.18%24h
Global rank529
Market cap$34.34B
Change 7d2.48%
YTD Performance44.80%
SP500 benchmarkOutperform
P/E-78.11
P/S18.78
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals (ALNY) Total Liabilities
ALNY Total Liabilities in 2022: $4.05B
According to Alnylam Pharmaceuticals latest financial reports the total liabilities of ALNY is $4.05B, an increase of 9.34% to 2022. At the end of 2022 company had $3.70B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Alnylam Pharmaceuticals is responsible for during its operational activities.
Alnylam Pharmaceuticals (ALNY) Total Liabilities History from 2023 to 2022
-
Value:-
ALNY Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $4.05B | 9.34% |
| 2022 | $3.70B | 21.26% |
| 2021 | $3.06B | 27.78% |
| 2020 | $2.39B | 149.97% |
| 2019 | $956.44M | 840.08% |
| 2018 | $101.74M | - |
View the Top Total Liabilies Stocks
